| Drug Name | Company Name | 2023 | 2024(F) | 2025(F) | 2026(F) | 2027(F) | 2028(F) | 2029(F) | 2030(F) | 2023 Growth($M) | 2023 Growth(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Erleada | Johnson & Johnson | $2,387 | $3,010 | $3,608 | $4,139 | $4,238 | $4,383 | $4,603 | $4,737 | $2,350 | 10.3% |
| Brukinsa | BeiGene Ltd | $1,290 | $2,104 | $2,682 | $3,287 | $3,824 | $4,279 | $4,313 | $4,716 | $3,426 | 20.3% |
| Gamunex/Gamimune N | Grifols SA | $3,564 | $3,776 | $4,004 | $4,204 | $4,371 | $4,546 | $4,683 | $4,683 | #DIV/0! | |
| Amvuttra | Alnylam Pharmaceuticals Inc | $558 | $868 | $1,198 | $1,670 | $2,315 | $3,193 | $3,901 | $4,617 | $4,059 | 35.2% |
| Calquence | AstraZeneca Plc | $2,514 | $3,091 | $3,483 | $3,847 | $4,092 | $4,286 | $4,447 | $4,588 | $2,074 | 9.0% |
| Bimzelx | UCB SA | $161 | $574 | $1,227 | $1,992 | $2,758 | $3,431 | $3,981 | $4,465 | $4,383 | 88.7% |
| Padcev | Pfizer Inc | $52 | $1,572 | $2,123 | $2,671 | $3,217 | $3,676 | $4,091 | $4,435 | $178 | 0.6% |
| Pluvicto | Novartis AG | $980 | $1,563 | $2,364 | $3,003 | $3,515 | $3,814 | $4,064 | $4,313 | $4,265 | #DIV/0! |
| Retatrutide | Eli Lilly and Co | - | - | $17 | $384 | $1,480 | $2,856 | $4,265 | $4,265 | #DIV/0! | |
| Imfinzi | AstraZeneca Plc | $4,734 | $5,374 | $5,861 | $6,249 | $6,546 | $6,808 | $7,050 | $7,050 | #DIV/0! | |
| Rybelsus | Novo Nordisk AS | $2,722 | $3,569 | $4,445 | $5,235 | $5,572 | $6,051 | $6,472 | $6,858 | $4,136 | 14.1% |
| Tecvayli | Johnson & Johnson | $395 | $551 | $1,295 | $2,308 | $2,922 | $3,467 | $4,409 | $6,440 | $6,045 | 49.0% |
| Winrevair | Merck & Co Inc | $552 | $1,947 | $3,050 | $3,997 | $4,806 | $5,665 | $6,325 | $6,325 | #DIV/0! | |
| Ultomiris | AstraZeneca Plc | $2,965 | $3,792 | $4,415 | $4,914 | $5,284 | $5,599 | $5,918 | $6,212 | $3,247 | 11.1% |
| Vyvgart | Argenx SE | $1,222 | $2,007 | $2,616 | $3,224 | $3,929 | $4,587 | $5,320 | $5,962 | $4,740 | 25.4% |
| Carvykti | Johnson & Johnson | $500 | $910 | $1,589 | $2,597 | $3,695 | $4,570 | $5,247 | $5,942 | $5,442 | 42.4% |
| Vanzacaftor + Deutivacaftor + Tezacaftor | Vertex Pharmaceuticals Inc | $19 | $1,129 | $2,249 | $3,384 | $4,476 | $5,521 | $5,887 | $5,887 | #DIV/0! | |
| Kesimpta | Novartis AG | $2,171 | $3,133 | $3,836 | $4,397 | $4,846 | $5,200 | $5,459 | $5,717 | $3,546 | 14.8% |
| Kisqali | Novartis AG | $2,080 | $3,041 | $4,080 | $5,154 | $6,103 | $6,881 | $7,629 | $8,096 | $6,016 | 21.4% |
| Eylea HD | Regeneron Pharmaceuticals Inc | $166 | $1,490 | $2,677 | $3,703 | $4,527 | $4,945 | $5,250 | $5,519 | $5,353 | 65.0% |
| Cagrisema | Novo Nordisk AS | - | $32 | $812 | $2,921 | $6,174 | $10,009 | $13,806 | $13,806 | #DIV/0! | |
| Enhertu | Daiichi Sankyo Co Ltd | $2,740 | $3,593 | $5,004 | $6,550 | $7,627 | $8,809 | $10,080 | $11,282 | $8,542 | 22.4% |
| Orforglipron Calcium | Eli Lilly and Co | - | - | $848 | $2,757 | $5,479 | $8,385 | $10,992 | $10,992 | #DIV/0! | |
| Cagrilintide | Novo Nordisk AS | - | - | $141 | $1,196 | $4,190 | $7,333 | $9,900 | $9,900 | #DIV/0! | |
| Zepbound | Eli Lilly and Co | $176 | $5,385 | $11,198 | $16,370 | $20,146 | $22,371 | $23,875 | $25,210 | $25,034 | 103.2% |
| Vabysmo | Roche Holding AG | $2,624 | $4,268 | $5,448 | $6,319 | $7,068 | $7,628 | $8,168 | $8,658 | $6,034 | 18.6% |
| Tremfya | Johnson & Johnson | $3,147 | $3,697 | $4,541 | $5,443 | $6,271 | $7,057 | $7,767 | $8,437 | $5,290 | 15.1% |
| Verzenio | Eli Lilly and Co | $3,863 | $5,196 | $6,233 | $7,107 | $7,743 | $8,163 | $8,472 | $8,784 | $4,921 | 12.5% |
| Invega Sustenna/Xeplion /Trinza /Trevicta | Johnson & Johnson | $4,115 | $4,202 | $4,272 | $4,373 | $4,469 | $4,571 | $4,667 | $4,765 | $650 | 2.1% |
| Rinvoq | AbbVie Inc | $3,969 | $5,741 | $7,420 | $8,997 | $10,310 | $11,425 | $12,323 | $13,172 | $9,203 | 18.7% |
| Tecentriq | Roche Holding AG | $4,192 | $4,161 | $4,274 | $4,386 | $4,479 | $4,520 | $4,506 | $4,370 | $3,333 | 23.6% |
| Wegovy | Novo Nordisk AS | $4,550 | $8,476 | $13,267 | $16,683 | $18,303 | $18,987 | $19,266 | $19,404 | $14,854 | 23.0% |
| Gammagard | Takeda Pharmaceutical Co Ltd | $4,461 | $5,223 | $5,678 | $6,080 | $6,477 | $6,893 | $7,326 | $7,783 | $3,322 | 8.3% |
| Shingrix | GSK plc | $4,285 | $4,756 | $5,270 | $5,780 | $5,968 | $6,054 | $6,156 | $6,239 | $1,954 | 5.5% |
| Mounjaro | Eli Lilly and Co | $5,163 | $11,823 | $17,368 | $22,067 | $25,532 | $28,631 | $30,668 | $32,439 | $27,276 | 30.0% |
| Cosentyx | Novartis AG | $4,980 | $6,007 | $6,568 | $7,025 | $7,404 | $7,650 | $7,324 | $6,163 | $1,183 | 3.1% |
| Hemlibra | Roche Holding AG | $4,616 | $4,914 | $5,227 | $5,461 | $5,596 | $5,636 | $5,677 | $5,581 | $965 | 2.7% |
| Tagrisso | AstraZeneca Plc | $5,799 | $6,392 | $6,830 | $7,161 | $7,421 | $7,610 | $7,601 | $7,700 | $1,901 | 4.1% |
| Entyvio | Takeda Pharmaceutical Co Ltd | $5,542 | $6,499 | $7,062 | $7,464 | $7,740 | $7,984 | $8,182 | $8,410 | $2,868 | 6.1% |
| Prevnar 13/Prevenar 13/Prevnar 20/Apexxnar | Pfizer Inc | $6,440 | $6,533 | $6,472 | $6,438 | $6,388 | $6,347 | $6,315 | $6,292 | ($148) | -0.3% |
| Ocrevus | Roche Holding AG | $7,103 | $7,594 | $8,053 | $8,411 | $8,618 | $8,520 | $8,141 | $7,785 | $682 | 1.3% |
| Gardasil/ Gardasil 9 | Merck & Co Inc | $8,886 | $9,618 | $10,202 | $10,756 | $11,139 | $11,437 | $11,688 | $11,902 | $3,016 | 4.3% |
| Trikafta/Kaftrio | Vertex Pharmaceuticals Inc | $8,945 | $8,950 | $10,438 | $10,613 | $10,762 | $10,749 | $10,788 | $11,031 | $2,086 | 3.0% |
| Opdivo | Bristol-Myers Squibb Co | $9,009 | $9,789 | $10,415 | $10,948 | $11,398 | $11,411 | $9,751 | $8,099 | ($910) | -1.5% |
| Skyrizi | AbbVie Inc | $7,763 | $10,981 | $13,785 | $16,195 | $17,979 | $19,487 | $20,645 | $21,676 | $13,913 | 15.8% |
| Biktarvy | Gilead Sciences Inc | $11,850 | $12,940 | $13,605 | $14,112 | $14,427 | $14,640 | $14,953 | $15,234 | $3,384 | 3.7% |
| Dupixent | Sanofi | $11,588 | $14,127 | $16,465 | $18,341 | $19,944 | $21,299 | $22,523 | $23,582 | $11,994 | 10.7% |
| Darzalex/Faspro | Johnson & Johnson | $9,744 | $11,510 | $13,277 | $15,076 | $16,789 | $18,308 | $19,799 | $20,095 | $10,351 | 10.9% |
| Ozempic | Novo Nordisk AS | $13,894 | $17,933 | $20,851 | $23,498 | $23,272 | $23,648 | $23,666 | $23,443 | $9,549 | 7.8% |
| Keytruda | Merck & Co Inc | $25,011 | $28,645 | $31,037 | $32,945 | $34,300 | $33,662 | $27,567 | $23,187 | ($1,824) | -1.1% |
Top 50 products based on 2030 Global forecast sales
The ranking of the top pharmaceutical companies has been compiled from GlobalData’s pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include data from 2023 and forecast data for 2024 to 2030.
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology